>アジア太平洋のインターベンショナルカーディオロジーおよび末梢血管デバイス市場、製品別 (血管形成術用バルーン、ステント、カテーテル、血管内動脈瘤修復用ステントグラフト、下大静脈 (IVC) フィルター、プラーク修正デバイス、血行動態フロー変更デバイスおよびその他および付属品)、タイプ別 (従来型および高度)、手順別 (腸骨動脈インターベンション、大腿膝窩動脈インターベンション、脛骨 (膝下) インターベンション、末梢血管形成術、動脈血栓除去術および末梢アテローム切除術)、適応症別 (末梢動脈疾患および冠動脈インターベンション)、年齢層別 (高齢者、成人および小児)、エンド ユーザー別 (病院、外来手術センター、介護施設、クリニックおよびその他)、流通チャネル別 (直接入札、サードパーティ ディストリビューターおよびその他）2029年までの業界動向と予測。
アジア太平洋地域のインターベンショナルカーディオロジーおよび末梢血管デバイス市場の分析と洞察
慢性疾患や慢性症状は世界中で増加しています。冠状動脈性心疾患 (CHD) は、そのリスク要因の多くが修正可能なため、大部分が予防可能です。リスク要因には、喫煙、高血圧や高血中コレステロールなどの生物医学的リスク要因、運動不足、不適切な食事や栄養、太りすぎや肥満などがあります。冠状動脈疾患や血管疾患の治療にかかる経済的負担は、入院、治療、血行再建術、通院、緊急通院、処方薬による治療によって生じます。
アジア太平洋地域のインターベンショナル心臓病および末梢血管デバイス市場の成長を牽引する要因としては、冠動脈疾患、虚血性心疾患、血管疾患の罹患率の増加、デバイスのタイムリーな治療と使用に関する意識の高まり、心臓病および末梢血管デバイスの技術的進歩、非侵襲性手術への関心の高まり、有利な償還方針などが挙げられます。ただし、市場の成長を抑制する要因として、デバイスのコスト上昇、デバイス使用中に観察されるリスク、製品リコールの増加、代替治療法の利用可能性などが挙げられます。
インターベンション心臓学および末梢血管デバイスはサポート的であり、病気の進行を抑えることを目的としています。データブリッジマーケットリサーチは、インターベンション心臓学および末梢血管デバイス市場は2022年から2029年の予測期間中に8.4％のCAGRで成長すると分析しています。
|
レポートメトリック |
詳細 |
|
予測期間 |
2022年から2029年 |
|
基準年 |
2021 |
|
歴史的な年 |
2020 (2019 - 2014 にカスタマイズ可能) |
|
定量単位 |
売上高は百万米ドル、価格は米ドル |
|
対象セグメント |
製品別（血管形成術用バルーン、ステント、カテーテル、血管内瘤修復用ステントグラフト、下大静脈（IVC）フィルター、プラーク修正装置、血行動態フロー変更装置、その他および付属品）、タイプ別（従来型および高度）、手順別（腸骨動脈インターベンション、大腿膝窩動脈インターベンション、脛骨（膝下）インターベンション、末梢血管形成術、動脈血栓摘出術および末梢アテローム切除術）、適応症別（末梢動脈疾患および冠動脈インターベンション）、年齢層別（高齢者、成人および小児）、エンドユーザー別（病院、外来手術センター、介護施設、クリニックおよびその他）、流通チャネル別（直接入札、サードパーティ販売業者およびその他） |
|
対象国 |
中国、日本、韓国、インド、オーストラリア、シンガポール、タイ、マレーシア、インドネシア、フィリピン、その他のアジア太平洋地域 |
|
対象となる市場プレーヤー |
Medtronic、BD、Cordis、Abbott、Boston Scientific Corporation、AngioDynamics、SMT、Edwards Lifesciences Corporation、Biosensors International Group、Ltd.、WL Gore & Associates、Inc.、Teleflex Incorporated、OrbusNeich Medical Company Limited、Merit Medical Systems、Terumo Medical Corporation、B. Braun Melsungen AG、MicroPort Scientific Corporation、Lepu Medical Technology(Beijing)Co.,Ltd、Koninklijke Philips NV |
アジア太平洋地域のインターベンショナルカーディオロジーおよび末梢血管デバイス市場の 動向
ドライバー
- 冠動脈疾患、虚血性心疾患、血管疾患などの慢性疾患の罹患率の増加
慢性疾患や慢性症状は世界中で増加しています。冠状動脈性心疾患 (CHD) は、そのリスク要因の多くが修正可能であるため、大部分は予防可能です。これには、喫煙、高血圧や高血中コレステロールなどの生物医学的リスク要因、不十分な身体活動、不適切な食事と栄養、太りすぎと肥満が含まれます。冠状動脈疾患と血管疾患の経済的負担は、入院、治療、血行再建手術、診療所への通院、緊急訪問、処方薬による治療から生じ、市場の成長を促進しています。
- 医療機器の取り扱いと使用に関する国民の認識
冠状動脈性心疾患は、女性の死亡原因の第 1 位です。心臓および血管疾患に関する知識は、健康的なライフスタイルにつながります。症状とその危険因子に関する適切な認識は、修正可能な危険因子への人々の曝露を減らすのに役立ち、それによって予防および管理戦略に貢献します。心血管疾患および血管疾患の症状に関する認識は、タイムリーな治療につながります。
また、これらの国々の有利な償還政策が市場の成長を促進すると予想されます。
さらに、主要企業による戦略的取り組みの増加、医療技術の進歩、心臓病学および末梢血管機器の最近の進歩、認知度を広めるための公的機関および民間組織による取り組みの増加、および政府資金の増加は、胃がん治療市場を拡大する要因となります。
機会
- 高齢化人口の増加
さらに、世界の高齢者人口は急速に増加しています。高齢者はさまざまな心血管疾患の罹患率がますます高くなっており、これは世界中で最も多く見られる死因と考えられており、市場の成長率に新たな機会をもたらすでしょう。
また、医薬品の承認数の増加は、2022～2029年の予測期間に、インターベンション心臓病学および末梢血管デバイス市場に有益な機会をもたらすでしょう。また、主要企業による提携や合意により、将来的にはインターベンション心臓病学および末梢血管デバイスの成長率が上昇するでしょう。
アジア太平洋地域のインターベンショナルカーディオロジーおよび末梢血管デバイス市場における制約/課題
しかし、カテーテルやバルーン血管形成装置のコストが上昇しているのは、技術の発展と、病院、診療所、介護施設、外来手術センターの心臓専門医による介入心臓学および末梢血管装置の需要増加によるものです。研究開発費の高さ、心臓学および末梢血管装置の臨床試験費用、市場要因により、ユニークな心臓学装置にはプレミアム価格が付きます。したがって、現在の高コストは将来的に下降傾向を示すことが予想されます。
このインターベンショナル カーディオロジーおよび末梢血管デバイス市場レポートでは、最近の新しい開発、貿易規制、輸出入分析、生産分析、バリュー チェーンの最適化、市場シェア、国内および現地の市場プレーヤーの影響、新たな収益源の観点から見た機会の分析、市場規制の変更、戦略的市場成長分析、市場規模、カテゴリ市場成長、アプリケーションのニッチと優位性、製品承認、製品発売、地理的拡張、市場における技術革新などの詳細が提供されます。インターベンショナル カーディオロジーおよび末梢血管デバイス市場の詳細については、アナリスト ブリーフについて Data Bridge Market Research にお問い合わせください。当社のチームが、市場成長を達成するための情報に基づいた市場決定を行うお手伝いをいたします。
COVID-19後のインターベンショナルカーディオロジーおよび末梢血管デバイス市場への影響
COVID-19 は、インターベンショナルカーディオロジーおよび末梢血管デバイス市場に悪影響を及ぼしています。パンデミック中のロックダウンと隔離は、病気の管理と服薬遵守を複雑にします。日常的な治療と投薬のための医療施設へのアクセスの欠如は、市場にさらなる影響を及ぼします。社会的孤立はストレス、絶望、社会的支援を増加させ、これらすべてがパンデミック中の抗けいれん薬の服薬遵守の低下を引き起こす可能性があります。
最近の開発
- メドトロニックは2021年9月13日、心血管疾患のクラウドベースの自動患者スクリーニングとケアパスウェイのスイートを提供することで知られるMpirikと提携したことを発表しました。この提携により、同社は高度な人工知能プラットフォームを使用して突然の心停止の予防に関連するケアの格差に対処し、市場でのリーダーシップをさらに向上させることができます。
アジア太平洋地域のインターベンショナルカーディオロジーおよび末梢血管デバイス市場の 範囲
アジア太平洋地域のインターベンショナル カーディオロジーおよび末梢血管デバイス市場は、製品、タイプ、手順、適応症、年齢層、エンド ユーザー、流通チャネルに基づいて、7 つの主要なセグメントに分類されます。これらのセグメントの成長は、業界のわずかな成長セグメントの分析に役立ち、ユーザーに貴重な市場の概要と市場洞察を提供して、コア市場アプリケーションを特定するための戦略的決定を下すのに役立ちます。
製品
- 血管形成術用バルーン
- ステント
- カテーテル
- 血管内動脈瘤修復ステントグラフト
- 下大静脈（IVC）フィルター
- プラーク修正装置
- 血行動態血流調節装置
- その他・アクセサリー
製品に基づいて、アジア太平洋地域のインターベンショナル心臓病学および末梢血管デバイス市場は、血管形成術用バルーン、ステント、カテーテル、血管内動脈瘤修復ステントグラフト、下大静脈（IVC）フィルター、プラーク修正デバイス、その他および付属品、血行動態フロー変更デバイスに分類されます。
タイプ
- 従来の
- 高度な
タイプに基づいて、アジア太平洋地域のインターベンショナル心臓病学および末梢血管デバイス市場は、従来型と高度型に分類されます。
手順
- 腸骨動脈インターベンション
- 大腿膝窩動脈介入
- 脛骨（膝下）介入
- 末梢血管形成術
- 動脈血栓除去術
- 末梢動脈瘤切除術
手順に基づいて、アジア太平洋地域のインターベンショナル心臓病学および末梢血管デバイス市場は、腸骨インターベンション、大腿膝窩動脈インターベンション、脛骨（膝下）インターベンション、末梢血管形成術、動脈血栓除去術、および末梢アテローム切除術に分類されます。
表示
- 末梢動脈疾患
- 冠動脈インターベンション
適応症に基づいて、アジア太平洋地域のインターベンショナル心臓病学および末梢血管デバイス市場は、末梢動脈疾患と冠動脈インターベンションに分類されます。
年齢層
- 老年病
- 大人
- 小児科
年齢層に基づいて、アジア太平洋地域のインターベンショナル心臓病学および末梢血管デバイス市場は、老年、成人、小児に分類されます。
エンドユーザー
- 病院
- 外来手術センター
- 介護施設
- クリニック
- その他
エンドユーザーに基づいて、アジア太平洋地域のインターベンショナル心臓病学および末梢血管デバイス市場は、病院、外来手術センター、介護施設、診療所、その他に分類されます。
流通チャネル
- 直接入札
- サードパーティ販売業者
- その他
流通チャネルに基づいて、アジア太平洋地域のインターベンショナル心臓病学および末梢血管デバイス市場は、直接入札、サードパーティの販売業者、その他に分類されます。
インターベンショナルカーディオロジーおよび末梢血管デバイス市場の 地域分析/洞察
インターベンショナル心臓病学および末梢血管デバイス市場が分析され、市場規模の洞察と傾向が、上記のように国、製品、タイプ、手順、適応症、年齢層、エンドユーザー、および流通チャネル別に提供されます。
胃がん治療市場レポートで取り上げられている国は、中国、日本、韓国、インド、オーストラリア、シンガポール、タイ、マレーシア、インドネシア、フィリピン、およびその他のアジア太平洋諸国です。
中国は、市場シェアと市場収益の面でインターベンション心臓病学および末梢血管デバイス市場を支配しており、予測期間中もその優位性を維持し続けるでしょう。これは、この国に主要なキープレーヤーが存在し、医療インフラが十分に整備されているためです。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と市場規制の変更も提供しています。新規販売と交換販売、国の人口統計、輸出入関税などのデータ ポイントは、個々の国の市場シナリオを予測するために使用される主要な指標の一部です。さらに、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、地元および国内ブランドとの激しい競争により直面する課題、販売チャネルの影響が考慮されています。
競争環境とインターベンショナルカーディオロジーおよび末梢血管デバイスの市場 シェア分析
インターベンショナル カーディオロジーおよび末梢血管デバイス市場の競争状況は、競合他社の詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、インターベンショナル カーディオロジーおよび末梢血管デバイス市場への会社の重点にのみ関連しています。
アジア太平洋地域のインターベンショナル心臓病学および末梢血管デバイス市場で事業を展開している大手企業には、メドトロニック、BD、コーディス、アボット、ボストン・サイエンティフィック・コーポレーション、アンジオダイナミクス、SMT、エドワーズ・ライフサイエンス・コーポレーション、バイオセンサーズ・インターナショナル・グループ、WLゴア・アンド・アソシエイツ、テレフレックス・インコーポレイテッド、オーバスネイチ・メディカル・カンパニー・リミテッド、メリット・メディカル・システムズ、テルモ・メディカル・コーポレーション、B. ブラウン・メルスンゲン AG、マイクロポート・サイエンティフィック・コーポレーション、レプ・メディカル・テクノロジー（北京）有限公司、コーニンクレッカ・フィリップスNVなどがあります。
研究方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。市場データは、市場統計モデルとコヒーレント モデルを使用して分析および推定されます。さらに、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数の市場への影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。これとは別に、データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、企業市場シェア分析、測定基準、グローバル対地域、ベンダー シェア分析が含まれます。さらに問い合わせる場合は、アナリストへの電話をリクエストしてください。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 THE RISE IN PREVALENCE OF CHRONIC DISEASES, SUCH AS CORONARY ARTERY DISEASE, ISCHEMIC HEART DISEASE AND VASCULAR DISEASES
6.1.2 AWARENESS AMONG THE POPULATION ABOUT THE TREATMENT AND USE OF THE DEVICES
6.1.3 TECHNOLOGICAL ADVANCEMENTS IN THE CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES
6.1.4 FAVORABLE REIMBURSEMENT POLICIES
6.1.5 INCREASED INTEREST FOR MINIMALLY INVASIVE PROCEDURES
6.2 RESTRAINTS
6.2.1 RISE IN COST OF THE CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES
6.2.2 RISKS OBSERVED WHILE USING INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES
6.2.3 RISE IN PRODUCT RECALL
6.2.4 AVAILABILITY OF ALTERNATE TREATMENTS
6.3 OPPORTUNITIES
6.3.1 GROWING GERIATRIC POPULATION
6.3.2 RISING HEALTHCARE EXPENDITURE
6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.4 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
6.4 CHALLENGES
6.4.1 STRINGENT RULES & REGULATIONS
6.4.2 LACK OF HOSPITAL INFRASTRUCTURE
7 IMPACT OF COVID-19 PANDEMIC ON THE MARKET
7.1 PRICE IMPACT
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS/ SERVICE PROVIDERS
7.5 CONCLUSION
8 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 ANGIOPLASTY BALLOONS
8.2.1 OLD/NORMAL BALLOONS
8.2.2 DRUG ELUTING BALLOONS
8.2.3 CUTTING AND SCORING BALLOONS
8.3 STENT
8.3.1 ANGIOPLASTY STENTS
8.3.2 CORONARY STENTS
8.3.2.1 BARE-METAL STENTS
8.3.2.2 DRUG-ELUTING STENTS (DES)
8.3.2.3 BIO ABSORBABLE STENTS
8.3.3 PERIPHERAL STENTS
8.3.4 OTHERS
8.4 CATHETERS
8.4.1 ANGIOGRAPHY CATHETERS
8.4.2 GUIDING CATHETERS
8.4.3 OTHERS
8.5 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
8.5.1 ABDOMINAL AORTIC ANEURYSM
8.5.2 THORACIC AORTIC ANEURYSM
8.6 INFERIOR VENA CAVA (IVC) FILTERS
8.6.1 RETRIEVABLE FILTERS
8.6.2 PERMANENT FILTERS
8.7 PLAQUE MODIFICATION DEVICES
8.7.1 THROMBECTOMY DEVICES
8.7.2 ATHERECTOMY DEVICES
8.8 HEMODYNAMIC FLOW ALTERATION DEVICES
8.8.1 EMBOLIC PROTECTION DEVICES
8.8.2 CHRONIC TOTAL OCCLUSION DEVICES
8.9 OTHERS AND ACCESSORIES
8.9.1 GUIDEWIRES
8.9.2 INTRODUCER SHEATHS
8.9.3 BALLOON INFLATION DEVICES
8.9.4 VASCULAR CLOSURE DEVICES
8.9.5 OTHERS
9 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE
9.1 OVERVIEW
9.2 CONVENTIONAL
9.2.1 STENTS
9.2.2 CATHETERS
9.2.3 GUIDEWIRES
9.2.4 VASCULAR CLOSURE DEVICES (VCD)
9.2.5 OTHERS
9.3 ADVANCED
9.3.1 BALLOON CATHETERS
9.3.2 STENT GRAFTS
10 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE
10.1 OVERVIEW
10.2 PERIPHERAL ANGIOPLASTY
10.2.1 ANGIOPLASTY BALLOONS
10.2.2 STENT
10.2.3 CATHETERS
10.2.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
10.2.5 INFERIOR VENA CAVA (IVC) FILTERS
10.2.6 PLAQUE MODIFICATION DEVICES
10.2.7 HEMODYNAMIC FLOW ALTERATION DEVICES
10.2.8 OTHERS AND ACCESSORIES
10.3 ILIAC INTERVENTION
10.3.1 ANGIOPLASTY BALLOONS
10.3.2 STENT
10.3.3 CATHETERS
10.3.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
10.3.5 INFERIOR VENA CAVA (IVC) FILTERS
10.3.6 PLAQUE MODIFICATION DEVICES
10.3.7 HEMODYNAMIC FLOW ALTERATION DEVICES
10.3.8 OTHERS AND ACCESSORIES
10.4 TIBIAL (BELOW-THE-KNEE) INTERVENTIONS
10.4.1 ANGIOPLASTY BALLOONS
10.4.2 STENT
10.4.3 CATHETERS
10.4.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
10.4.5 INFERIOR VENA CAVA (IVC) FILTERS
10.4.6 PLAQUE MODIFICATION DEVICES
10.4.7 HEMODYNAMIC FLOW ALTERATION DEVICES
10.4.8 OTHERS AND ACCESSORIES
10.5 ARTERIAL THROMBECTOMY
10.5.1 ANGIOPLASTY BALLOONS
10.5.2 STENT
10.5.3 CATHETERS
10.5.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
10.5.5 INFERIOR VENA CAVA (IVC) FILTERS
10.5.6 PLAQUE MODIFICATION DEVICES
10.5.7 HEMODYNAMIC FLOW ALTERATION DEVICES
10.5.8 OTHERS AND ACCESSORIES
10.6 PERIPHERAL ATHERECTOMY
10.6.1 ANGIOPLASTY BALLOONS
10.6.2 STENT
10.6.3 CATHETERS
10.6.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
10.6.5 INFERIOR VENA CAVA (IVC) FILTERS
10.6.6 PLAQUE MODIFICATION DEVICES
10.6.7 HEMODYNAMIC FLOW ALTERATION DEVICES
10.6.8 OTHERS AND ACCESSORIES
10.7 FEMOROPOPLITEAL INTERVENTIONS
10.7.1 ANGIOPLASTY BALLOONS
10.7.2 STENT
10.7.3 CATHETERS
10.7.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
10.7.5 INFERIOR VENA CAVA (IVC) FILTERS
10.7.6 PLAQUE MODIFICATION DEVICES
10.7.7 HEMODYNAMIC FLOW ALTERATION DEVICES
10.7.8 OTHERS AND ACCESSORIES
11 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION
11.1 OVERVIEW
11.2 PERIPHERAL ARTERIAL DISEASE
11.2.1 ATHEROSCLEROSIS
11.2.2 ABDOMINAL AORTIC ANEURYSM
11.2.3 LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE
11.2.4 SUPRA-INGUINAL ARTERIAL DISEASE
11.2.5 INFRA-INGUINAL ARTERIAL DISEASE
11.2.6 INFRA-POPLITEAL DISEASE
11.2.7 UPPER EXTREMITY OCCLUSIVE DISEASE
11.2.8 CAROTID ARTERY DISEASE
11.2.9 OTHERS
11.3 CORONARY INTERVENTION
11.3.1 ISCHEMIC HEART DISEASE
11.3.2 THORACIC AORTIC ANEURYSM
11.3.3 VALVE DISEASE
11.3.4 PERCUTANEOUS VALVE REPAIR OR REPLACEMENT
11.3.5 CONGENITAL HEART ABNORMALITIES
11.3.6 OTHERS
12 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP
12.1 OVERVIEW
12.2 GERIATRIC
12.3 ADULTS
12.4 PEDIATRIC
13 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.2.1 PRIVATE
13.2.2 PUBLIC
13.3 AMBULATORY SURGICAL CENTERS
13.4 NURSING FACILITIES
13.5 CLINICS
13.6 OTHERS
14 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 THIRD PARTY DISTRIBUTORS
14.3 DIRECT TENDER
14.4 OTHERS
15 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY
15.1 ASIA PACIFIC
15.1.1 CHINA
15.1.2 INDIA
15.1.3 JAPAN
15.1.4 SOUTH KOREA
15.1.5 AUSTRALIA
15.1.6 SINGAPORE
15.1.7 THAILAND
15.1.8 MALAYSIA
15.1.9 INDONESIA
15.1.10 PHILIPPINES
15.1.11 REST OF ASIA PACIFIC
16 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 BOSTON SCIENTIFIC CORPORATION
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 PRODUCT PORTFOLIO
18.1.4 RECENT DEVELOPMENT
18.1.5 ACQUSITION
18.2 CORDIS.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENTS
18.2.5 PRODUCT LAUNCHES
18.3 ABBOTT
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 PRODUCT PORTFOLIO
18.3.4 RECENT DEVELOPMENTS
18.3.5 PRODUCT LAUNCHES
18.4 BD (2021)
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENT
18.5 TERUMO CORPORATION
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 PRODUCT PORTFOLIO
18.5.4 RECENT DEVELOPMENTS
18.5.5 PARTNERSHIP
18.5.6 PRODUCT LAUNCH
18.6 ANGIODYNAMICS.(2021)
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENTS
18.7 B. BRAUN MELSUNGEN AG (2021)
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENTS
18.8 BIOSENSORS INTERNATIONAL GROUP, LTD.
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 EDWARDS LIFESCIENCES CORPORATION
18.9.1 COMPANY SNAPSHOT
18.9.2 REVENUE ANALYSIS
18.9.3 PRODUCT PORTFOLIO
18.9.4 RECENT DEVELOPMENTS
18.1 KONINKLIJKE PHILIPS N.V.
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 PRODUCT PORTFOLIO
18.10.4 RECENT DEVELOPMENTS
18.10.5 PRODUCT UPDATES
18.11 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. (2021)
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENT
18.12 MEDTRONIC
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENTS
18.12.5 COLLABORATION
18.12.6 PRODUCT LAUNCH
18.13 MERIT MEDICAL SYSTEM
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 MICROPORT SCIENTIFIC CORPORATION.
18.14.1 COMPANY SNAPSHOT
18.14.2 REVENUE ANALYSIS
18.14.3 PRODUCT PORTFOLIO
18.14.4 RECENT DEVELOPMENTS
18.14.4.1 PRODUCT APPROVALS
18.15 ORBUSNEICH MEDICAL COMPANY LIMITED
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.15.4 PRODUCT LAUNCH
18.16 SMT
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENTS
18.17 TELEFLEX INCORPORATED.
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 PRODUCT PORTFOLIO
18.17.4 RECENT DEVELOPMENTS
18.17.5 ACQUISITIONS
18.18 W. L. GORE & ASSOCIATES, INC.
18.18.1 COMPANY SNAPSHOT
18.18.2 PRODUCT PORTFOLIO
18.18.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
表のリスト
TABLE 1 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 2 ASIA-PACIFIC ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 3 ASIA-PACIFIC STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 4 ASIA-PACIFIC CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 5 ASIA-PACIFIC CATHETERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 6 ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 7 ASIA-PACIFIC INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 8 ASIA-PACIFIC PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 9 ASIA-PACIFIC HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 10 ASIA-PACIFIC OTHER AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 11 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 12 ASIA-PACIFIC CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 13 ASIA-PACIFIC ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 14 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 15 ASIA-PACIFIC PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 16 ASIA-PACIFIC ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 17 ASIA-PACIFIC TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 18 ASIA-PACIFIC ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 19 ASIA-PACIFIC PERIPHERAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 20 ASIA-PACIFIC FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 21 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 22 ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 23 ASIA-PACIFIC CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 24 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 25 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 26 ASIA-PACIFIC HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 27 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 33 ASIA PACIFIC CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 35 ASIA PACIFIC INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 36 ASIA PACIFIC PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 37 ASIA PACIFIC HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 38 ASIA PACIFIC OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 39 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 40 ASIA PACIFIC CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 41 ASIA PACIFIC ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 42 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 43 ASIA PACIFIC ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 44 ASIA PACIFIC FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 45 ASIA PACIFIC TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 46 ASIA PACIFIC PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 47 ASIA PACIFIC ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 48 ASIA PACIFIC PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 49 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 50 ASIA PACIFIC PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 51 ASIA PACIFIC CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 52 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 53 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 54 ASIA PACIFIC HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 55 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 56 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 57 CHINA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 58 CHINA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 59 CHINA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 60 CHINA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 61 CHINA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 62 CHINA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 63 CHINA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 64 CHINA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 65 CHINA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 66 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 67 CHINA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 68 CHINA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 69 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 70 CHINA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 71 CHINA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 72 CHINA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 73 CHINA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 74 CHINA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 75 CHINA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 76 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 77 CHINA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 78 CHINA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 79 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 80 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 81 CHINA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 82 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 83 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 84 INDIA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 85 INDIA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 86 INDIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 87 INDIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 88 INDIA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 89 INDIA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 90 INDIA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 91 INDIA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 92 INDIA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 93 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 94 INDIA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 95 INDIA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 96 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 97 INDIA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 98 INDIA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 99 INDIA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 100 INDIA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 101 INDIA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 102 INDIA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 103 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 104 INDIA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 105 INDIA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 106 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 107 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 108 INDIA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 109 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 110 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 111 JAPAN ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 112 JAPAN STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 113 JAPAN CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 114 JAPAN CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 115 JAPAN ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 116 JAPAN INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 117 JAPAN PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 118 JAPAN HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 119 JAPAN OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 120 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 121 JAPAN CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 122 JAPAN ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 123 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 124 JAPAN ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 125 JAPAN FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 126 JAPAN TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 127 JAPAN PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 128 JAPAN ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 129 JAPAN PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 130 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 131 JAPAN PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 132 JAPAN CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 133 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 134 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 135 JAPAN HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 136 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 137 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 138 SOUTH KOREA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 139 SOUTH KOREA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 140 SOUTH KOREA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 141 SOUTH KOREA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 142 SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 143 SOUTH KOREA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 144 SOUTH KOREA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 145 SOUTH KOREA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 146 SOUTH KOREA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 147 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 148 SOUTH KOREA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 149 SOUTH KOREA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 150 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 151 SOUTH KOREA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 152 SOUTH KOREA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 153 SOUTH KOREA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 154 SOUTH KOREA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 155 SOUTH KOREA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 156 SOUTH KOREA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 157 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 158 SOUTH KOREA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 159 SOUTH KOREA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 160 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 161 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 162 SOUTH KOREA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 163 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 164 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 165 AUSTRALIA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 166 AUSTRALIA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 167 AUSTRALIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 168 AUSTRALIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 169 AUSTRALIA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 170 AUSTRALIA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 171 AUSTRALIA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 172 AUSTRALIA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 173 AUSTRALIA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 174 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 175 AUSTRALIA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 176 AUSTRALIA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 177 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 178 AUSTRALIA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 179 AUSTRALIA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 180 AUSTRALIA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 181 AUSTRALIA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 182 AUSTRALIA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 183 AUSTRALIA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 184 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 185 AUSTRALIA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 186 AUSTRALIA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 187 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 188 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 189 AUSTRALIA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 190 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 191 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 192 SINGAPORE ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 193 SINGAPORE STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 194 SINGAPORE CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 195 SINGAPORE CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 196 SINGAPORE ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 197 SINGAPORE INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 198 SINGAPORE PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 199 SINGAPORE HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 200 SINGAPORE OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 201 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 202 SINGAPORE CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 203 SINGAPORE ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 204 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 205 SINGAPORE ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 206 SINGAPORE FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 207 SINGAPORE TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 208 SINGAPORE PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 209 SINGAPORE ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 210 SINGAPORE PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 211 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 212 SINGAPORE PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 213 SINGAPORE CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 214 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 215 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 216 SINGAPORE HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 217 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 218 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 219 THAILAND ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 220 THAILAND STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 221 THAILAND CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 222 THAILAND CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 223 THAILAND ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 224 THAILAND INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 225 THAILAND PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 226 THAILAND HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 227 THAILAND OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 228 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 229 THAILAND CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 230 THAILAND ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 231 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 232 THAILAND ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 233 THAILAND FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 234 THAILAND TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 235 THAILAND PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 236 THAILAND ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 237 THAILAND PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 238 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 239 THAILAND PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 240 THAILAND CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 241 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 242 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 243 THAILAND HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 244 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 245 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 246 MALAYSIA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 247 MALAYSIA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 248 MALAYSIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 249 MALAYSIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 250 MALAYSIA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 251 MALAYSIA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 252 MALAYSIA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 253 MALAYSIA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 254 MALAYSIA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 255 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 256 MALAYSIA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 257 MALAYSIA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 258 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 259 MALAYSIA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 260 MALAYSIA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 261 MALAYSIA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 262 MALAYSIA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 263 MALAYSIA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 264 MALAYSIA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 265 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 266 MALAYSIA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 267 MALAYSIA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 268 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 269 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 270 MALAYSIA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 271 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 272 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 273 INDONESIA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 274 INDONESIA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 275 INDONESIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 276 INDONESIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 277 INDONESIA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 278 INDONESIA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 279 INDONESIA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 280 INDONESIA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 281 INDONESIA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 282 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 283 INDONESIA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 284 INDONESIA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 285 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 286 INDONESIA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 287 INDONESIA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 288 INDONESIA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 289 INDONESIA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 290 INDONESIA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 291 INDONESIA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 292 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 293 INDONESIA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 294 INDONESIA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 295 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 296 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 297 INDONESIA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 298 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 299 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 300 PHILIPPINES ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 301 PHILIPPINES STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 302 PHILIPPINES CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 303 PHILIPPINES CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 304 PHILIPPINES ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 305 PHILIPPINES INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 306 PHILIPPINES PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 307 PHILIPPINES HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 308 PHILIPPINES OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 309 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 310 PHILIPPINES CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 311 PHILIPPINES ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 312 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 313 PHILIPPINES ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 314 PHILIPPINES FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 315 PHILIPPINES TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 316 PHILIPPINES PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 317 PHILIPPINES ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 318 PHILIPPINES PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 319 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 320 PHILIPPINES PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 321 PHILIPPINES CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 322 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 323 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 324 PHILIPPINES HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 325 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 326 REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
図表一覧
FIGURE 1 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DBMR POSITION GRID
FIGURE 8 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: END USER COVERAGE GRID
FIGURE 10 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SEGMENTATION
FIGURE 11 INCREASED PREVALENCE OF CHRONIC CARDIAC DISEASES, RISE IN TECHNOLOGICAL ADVANCEMENTS IN NON-INVASIVE SURGERIES AND PRODUCT APPPROVALS IS EXPECTED TO DRIVE ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET FROM 2022 TO 2029
FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET FROM 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET
FIGURE 14 GLOBAL PREVALENCE AND DISABILITY RATE OF ISCHEMIC HEART DISEASE (IHD) IN 2021
FIGURE 15 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, 2021
FIGURE 16 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, 2022-2029 (USD MILLION)
FIGURE 17 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, CAGR (2022-2029)
FIGURE 18 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 19 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, 2021
FIGURE 20 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 21 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 22 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, 2021
FIGURE 24 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, 2022-2029 (USD MILLION)
FIGURE 25 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, CAGR (2022-2029)
FIGURE 26 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE
FIGURE 27 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, 2021
FIGURE 28 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, 2022-2029 (USD MILLION)
FIGURE 29 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, CAGR (2022-2029)
FIGURE 30 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 31 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, 2021
FIGURE 32 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, 2022-2029 (USD MILLION)
FIGURE 33 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, CAGR (2022-2029)
FIGURE 34 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 35 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, 2021
FIGURE 36 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 37 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 38 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 39 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 40 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 41 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 42 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 43 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SNAPSHOT (2021)
FIGURE 44 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY COUNTRY (2021)
FIGURE 45 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 46 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 47 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT (2021-2029)
FIGURE 48 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: COMPANY SHARE 2021 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
